Trial Profile
Fixed-sequence, open-label, 2-period study investigating the effect of concomitant administration of doravirine on the pharmacokinetics of atorvastatin in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2015
Price :
$35
*
At a glance
- Drugs Doravirine (Primary) ; Atorvastatin
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 24 Oct 2015 New trial record
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.